Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...
Dr. Raches Ella, Chief Development Officer, Bharat Biotech, spearheading this CGT initiative, said that oncology and rare ...
In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...
Development strategies designed to reduce the unknowns so that cell and gene therapy innovators can develop robust processes ...
In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with ...
The strategic partnership aims to optimize the delivery of Genprex's diabetes gene therapy using a non-viral lipid nanoparticle system. This method could offer the possibility of re-dosing ...
"Stargardt disease has remained elusive to gene therapies due to the large size of the ABCA4 gene. SB-007 is the first gene therapy in clinical development designed to restore expression of the ...
Sarepta Therapeutics said on Tuesday that a 16-year-old boy died from acute liver failure months after receiving the company's U.S-approved gene therapy for a rare muscular dystrophy. The patient ...
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...
Biotherapeutics announced promising preclinical results for its systemic RTNova platform. The platform has successfully delivered ...